/ /

CLINICAL

Refractive year characterized by expanding array of treatment choices
Drug, device innovations making strides for glaucoma care in 2017Glaucoma innovations in 2017 included advancements in new drugs, new microinvasive glaucoma surgery devices, and a new diagnostic tool. Two glaucoma specialists review some of the year’s highlights.
Can cannabis succeed where other compounds have failedUse of a novel semi-fluorinated alkane drug delivery technology as a vehicle to deliver cannabinoids to the ocular surface reached target tissues without systemic side effects in preclinical studies.
Opportunities and challenges in the world of ophthalmology in 2018As another year comes to an end, five members of Ophthalmology Times Europe’s Editorial Advisory Board reflect and share their perspectives on the exciting opportunities that lie ahead for ophthalmologists in 2018, whilst also considering the potential challenges.
Isopropyl nitrate poppers pose maculopathy riskPoppers containing isopropyl nitrate may cause foveal maculopathy, researchers say.
How tear osmolarity affects lens wearConsidering that many CL patients are desensitized, it is critical we not only monitor their tear film and ocular surface for change, but we demonstrate stability or instability through measurable means. This creates trust, validates our recommendations, induces compliance, and generates positive outcomes.
Work with patients to combat contact lens obsolescenceObsolescence happens. If you are not familiar with it, it is the act of becoming obsolete or out of date.
Tear osmolarity: Dry eye's 'vital sign'Hyperosmolarity emerges as key mechanism in TFOS DEWS II pathophysiology report
Biologic products increase dry eye optionsMany new diagnostic tools are available for dry eye and ocular surface disease (OSD). Treatments for dry eye and OSD have mixed results, however, said Bennie H. Jeng, MD.
TFOS DEWS II report introduces new patient classification schemeJ. Daniel Nelson, MD, chair of The Tear Film and Ocular Surface Society Dry Eye Workshop II, highlights a new scheme for patient classification.